Reproductive performance of Holstein cows administered GnRH analog HOE 766 (Buserelin) 26 to 34 days postpartum.
During the fourth week postpartum, 443 healthy Holstein cows milked thrice daily were randomly divided among four groups to receive 0, 2, 8 and 32 micrograms of the GnRH analog HOE 766. Intervals from calving to first estrus and to first breeding, from breeding to conception and conception rates at first breeding were calculated to measure treatment response, and progesterone was measured in the fat-free portion of milk samples collected twice weekly during the first 4 wk following treatment. Uterine involution at the time of treatment was estimated by palpation per rectum. Twenty percent of the cows examined were classified as having delayed uterine involution (abnormal). By analyzing milk progesterone patterns it was determined that 38% of the animals were in the luteal phase of an estrous cycle when treated. Cows without luteal tissue (less than 1 ng of progesterone/ml milk) given 8 or 32 micrograms of HOE 766 increased in progesterone to greater than or equal to 1 ng/ml within 7 d in 77 and 72% of the cows compared with 40 and 57% for cows receiving 0 and 2 micrograms (P less than .05). This increase in progesterone was followed by a normal estrous cycle within 4 wk in a higher proportion of cows treated with the two higher doses of GnRH analog (87 and 86%) compared with 67 and 70% of those receiving 0 or 2 micrograms of the analog (P less than .005). There were no treatment differences (P greater than .05) for other traits analyzed, but cows with a normal progesterone cycle were observed in estrus and were bred sooner (P less than .01) than those with irregular progesterone patterns. It was concluded that the GnRH analog hastened the onset of normal ovarian cycles in cows milked thrice daily.
D000818:Animals; D002064:Buserelin / Q000494:pharmacology*; D002417:Cattle / Q000502:physiology*; D004971:Estrus / Q000187:drug effects; D005260:Female; D008183:Luteal Phase / Q000187:drug effects; D008892:Milk / Q000378:metabolism; D010053:Ovary / Q000187:drug effects / Q000502:physiology; D049590:Postpartum Period; D011247:Pregnancy; D011374:Progesterone / Q000378:metabolism; D012098:Reproduction / Q000187:drug effects*; D014599:Uterus / Q000187:drug effects / Q000502:physiology
D011374:Progesterone; D002064:Buserelin